IL232386A0 - Preparations containing halophanate or halophanic acid and a substance that lowers urate and their uses - Google Patents
Preparations containing halophanate or halophanic acid and a substance that lowers urate and their usesInfo
- Publication number
- IL232386A0 IL232386A0 IL232386A IL23238614A IL232386A0 IL 232386 A0 IL232386 A0 IL 232386A0 IL 232386 A IL232386 A IL 232386A IL 23238614 A IL23238614 A IL 23238614A IL 232386 A0 IL232386 A0 IL 232386A0
- Authority
- IL
- Israel
- Prior art keywords
- halofenate
- urate
- compositions
- lowering agent
- halofenic acid
- Prior art date
Links
- BJBCSGQLZQGGIQ-UHFFFAOYSA-N 2-acetamidoethyl 2-(4-chlorophenyl)-2-[3-(trifluoromethyl)phenoxy]acetate Chemical compound C=1C=C(Cl)C=CC=1C(C(=O)OCCNC(=O)C)OC1=CC=CC(C(F)(F)F)=C1 BJBCSGQLZQGGIQ-UHFFFAOYSA-N 0.000 title 1
- 239000002253 acid Substances 0.000 title 1
- 239000003795 chemical substances by application Substances 0.000 title 1
- 229950000958 halofenate Drugs 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2011/059394 WO2013066349A1 (en) | 2011-11-04 | 2011-11-04 | Methods for treating hyperuricemia in patients with gout using halofenate or halofenic acid and a second urate-lowering agent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL232386A0 true IL232386A0 (en) | 2014-06-30 |
Family
ID=48192533
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL232386A IL232386A0 (en) | 2011-11-04 | 2014-04-30 | Preparations containing halophanate or halophanic acid and a substance that lowers urate and their uses |
Country Status (13)
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104602686A (zh) * | 2012-04-13 | 2015-05-06 | 西玛贝医药公司 | 利用卤芬酯或卤芬酸以及抗炎剂治疗痛风患者中高尿酸血症的方法 |
| TWI705812B (zh) | 2014-12-01 | 2020-10-01 | 奥默羅斯公司 | 用於抑制術後眼睛炎性病況的抗炎和散瞳前房溶液 |
| JP6368756B2 (ja) * | 2016-10-20 | 2018-08-01 | サイマベイ・セラピューティクス・インコーポレイテッドＣｙｍａＢａｙ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． | ハロフェナートまたはハロフェン酸および第２の尿酸低下薬を用いる痛風に罹っている患者の高尿酸血症の治療方法 |
| CN108014108A (zh) * | 2016-11-03 | 2018-05-11 | 江苏万邦生化医药股份有限公司 | lesinurad或其医药上可接受的盐在制备治疗或预防库欣综合征的药物中的应用 |
| WO2019082335A1 (ja) * | 2017-10-26 | 2019-05-02 | 大塚製薬株式会社 | イノシトールリン酸含有組成物 |
| WO2021186250A2 (en) * | 2020-03-15 | 2021-09-23 | Allen Davidoff | Methods of treating viral infections and health consequences |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6262118B1 (en) * | 1999-06-04 | 2001-07-17 | Metabolex, Inc. | Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia |
| US7576131B2 (en) * | 1999-06-04 | 2009-08-18 | Metabolex, Inc. | Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia |
| WO2011032175A1 (en) * | 2009-09-14 | 2011-03-17 | Nuon Therapeutics, Inc. | Combination formulations of tranilast and allopurinol and methods related thereto |
| US9023856B2 (en) * | 2011-11-04 | 2015-05-05 | Cymabay Therapeutics, Inc. | Methods for treating hyperuricemia in patients with gout using halofenate or halogenic acid and a second urate-lowering agent |
-
2011
- 2011-11-04 MX MX2014005400A patent/MX357507B/es active IP Right Grant
- 2011-11-04 WO PCT/US2011/059394 patent/WO2013066349A1/en active Application Filing
- 2011-11-04 SG SG11201402032RA patent/SG11201402032RA/en unknown
- 2011-11-04 EP EP11875114.8A patent/EP2773336A4/en not_active Withdrawn
- 2011-11-04 KR KR1020147015169A patent/KR20140121383A/ko not_active Abandoned
- 2011-11-04 CA CA2859686A patent/CA2859686C/en not_active Expired - Fee Related
- 2011-11-04 AU AU2011380507A patent/AU2011380507B2/en not_active Ceased
- 2011-11-04 CN CN201910004813.0A patent/CN109908124A/zh active Pending
- 2011-11-04 JP JP2014541011A patent/JP6202633B2/ja not_active Expired - Fee Related
- 2011-11-04 CN CN201180076191.4A patent/CN104066427A/zh active Pending
- 2011-11-04 NZ NZ624708A patent/NZ624708A/en not_active IP Right Cessation
-
2014
- 2014-04-30 IL IL232386A patent/IL232386A0/en unknown
- 2014-05-02 CL CL2014001155A patent/CL2014001155A1/es unknown
- 2014-05-16 ZA ZA2014/03575A patent/ZA201403575B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2859686A1 (en) | 2013-05-10 |
| CA2859686C (en) | 2018-09-11 |
| CN109908124A (zh) | 2019-06-21 |
| EP2773336A4 (en) | 2015-06-03 |
| JP6202633B2 (ja) | 2017-09-27 |
| MX357507B (es) | 2018-07-12 |
| WO2013066349A1 (en) | 2013-05-10 |
| AU2011380507A1 (en) | 2014-05-29 |
| EP2773336A1 (en) | 2014-09-10 |
| JP2014532758A (ja) | 2014-12-08 |
| CN104066427A (zh) | 2014-09-24 |
| ZA201403575B (en) | 2015-11-25 |
| SG11201402032RA (en) | 2014-09-26 |
| CL2014001155A1 (es) | 2015-01-16 |
| AU2011380507B2 (en) | 2017-06-15 |
| KR20140121383A (ko) | 2014-10-15 |
| NZ624708A (en) | 2015-11-27 |
| MX2014005400A (es) | 2015-02-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL250259B (en) | Preparations containing ursolic acid or its derivative and their uses | |
| AP3821A (en) | Pesticidal compositions and processes related thereto | |
| ZA201302894B (en) | Pesticidal compositions and processes related thereto | |
| EP2646468A4 (en) | ANTI-NGF COMPOSITIONS AND THEIR USE | |
| IL232113A0 (en) | Arginase inhibitor compounds, preparations containing them and their uses | |
| ZA201209259B (en) | Uses and compositions | |
| ZA201404283B (en) | Compositions comprising gallates and gallamides | |
| PT2758052T (pt) | Composição farmacêutica que compreende um inibidor de hdac e um ciclopolissacárido | |
| ZA201402321B (en) | Compositions comprising salbutamol sulphate | |
| GB201006096D0 (en) | Novel compositions and uses thereof | |
| ZA201305749B (en) | Pesticidal compositions and processes related thereof | |
| SG10202112138QA (en) | Compositions comprising peg and sulphate | |
| GB201113770D0 (en) | Novel compositions and uses thereof | |
| ZA201402234B (en) | Compositions comprising salbutamol sulphate | |
| EP2768909A4 (en) | INK FORMULATION AND ITS MANUFACTURE | |
| EP2753341A4 (en) | ANTIMICROBIAL COMPOSITIONS AND USES THEREOF | |
| EP2755486A4 (en) | DISINFECTING COMPOSITIONS AND USES THEREOF | |
| IL232386A0 (en) | Preparations containing halophanate or halophanic acid and a substance that lowers urate and their uses | |
| GB201106357D0 (en) | Composition and uses thereof | |
| ZA201208412B (en) | Composition comprising cinnamon | |
| PL2648715T3 (pl) | Mieszaniny karnozyny-kwasu hialuronowego i ich zastosowanie | |
| EP2668044A4 (en) | COMPOSITIONS AND THEIR USE | |
| IL228403A0 (en) | Preparations containing anti-influenza antibodies and osetamivir and their uses | |
| EP2542059A4 (en) | COMPOSITIONS COMPRISING MYRISTIC ACID AND USES THEREOF | |
| GB201005826D0 (en) | New compositions and their use |